Efficacy and adherence of auto-CPAP therapy in patients with obstructive sleep apnea: a prospective study

• Published in: Multidisciplinary respiratory medicine 2020-01, Vol.15 (1), p.468-468
• Main Authors: Dinh-Thi-Dieu, Hang, Vo-Thi-Kim, Anh, Tran-Van, Huong, Duong-Quy, Sy
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 1828-695X; 2049-6958
• DOI: 10.4081/mrm.2020.468

The use of auto-continuous positive airway pressure (auto-CPAP) therapy has been recommended for subjects with moderate-to-severe obstructive sleep apnea (OSA) without significant comorbidities. This study is aimed at evaluating the efficacy and adherence of auto-CPAP therapy in subjects with OSA. It was a perspective and descriptive study. All study subjects who had apnea-hypopnea index (AHI) > 30/h, measured by polysomnography, were included. They were treated with auto-CPAP and followed-up for 6 months for evaluating the effect of CPAP-therapy on clinical and biological features and treatment adherence. One hundred and thirty-nine subjects with severe OSA were accepted for auto-CPAP therapy at inclusion. BMI was 28.4±3.8 kg/m ; neck and abdomen circumferences were 38.2±6.4 and 85.7±11.6. Epworth and Pichot scores were 18.4±6.3 and 28.3±4.5, respectively; AHI was 39±7/h and arousal index was 39±13/h. At 6 month, 96.4% of study subjects continued to use auto-CPAP-therapy within 6.5±2.4 h/night. There was a significant correlation between the modification (Δ) of Epworth scores and (Δ) AHI after 3 and 6 months of auto-CPAP-therapy (R=0.568 and =0.003; R=0.745 and =0.002; respectively). At 6 month follow up, the main side effects of auto-CPAP were difficult sleeping, dry mouth or nose, skin marks or rashes, discomfort when breathing, and nasal congestion (36.1%, 32.0%, 20.8%, 16.0%, and 11.9%, respectively). Auto-CPAP is effective in treatment of Vietnamese patients with severe OSA in short term follow up.